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Sigmoidal relationship between calcitonin and calcium: Studies in
normal, parathyroidectomized, and azotemic rats. Calcitonin secretion is
stimulated by acute hypercalcemia. Furthermore, in the rat, the calce-
mic response to parathyroid hormone (PTH) is decreased by calcitonin
stimulation. However, in renal failure, it is not known if an increase in
the serum calcium Concentration within the physiologic range of serum
calcium stimulates calcitonin and whether the increased calcitonin
decreases the calcemic response to PTH. In the present study, four
groups of pair-fed rats were evaluated: normals (N); parathyroidectomy
(PTX); and two groups with renal failure (RF)—basal serum calcium <
8.5 mg/dl (RFa) and basal serum calcium > 8.5 mg/dl (RFb). Hypo-
calcemia was induced by parathyroidectomy or in the RFa group, by a
high phosphate diet. Increases in the serum calcium were produced by
a 48 hour infusion of rat 1-34 PTH. In the RFa and PTX groups,
stimulation of calcitonin was observed as the serum calcium increased
from hypocalcemia to normal levels of calcium (P < 0.01). In all four
groups, increasing the serum calcium from normal levels to hypercal-
cemia increased the serum calcitonin level (P < 0.05). The relationship
between serum calcitonin and calcium was best expressed as a sigmoi-
dal curve. In the two groups with basal hypocalcemia, PTX and RFa,
the calcitonin-calcium curve was shifted to the left of the N and RFb
groups. In conclusion, 1) the presence of a calcitonin-calcium curve
suggests the possibility of a regulatory function for calcitonin during
acute increases in the serum calcium; 2) the basal serum calcium
concentration may determine the calcium level at which calcitonin is
stimulated; and 3) the stimulation of calcitonin in the physiologic range
of serum calcium suggests that endogenous calcitonin production may
decrease the calcemic response to PTH in renal failure.
Calcitonin, a 32 amino-acid peptide-hormone, is synthesized
and secreted by the C-cells of the thyroid gland [1, 2]. Acute
hypercalcemia is a recognized stimulus for calcitonin secretion
[1, 2]. Moreover, in both humans and rats, an increase in the
blood calcium concentration within the physiologic range pro-
duces an increase in the serum calcitonin level [3, 4].
Elevation of the serum calcitonin level has been observed in
both humans and rats with renal failure [5—8]; this has been
attributed to decreased renal clearance of calcitonin [9, 10].
Moreover, in renal failure, the role of calcitonin on calcium
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regulation is not well defined. In our recent study in rats, we
found that stimulation of calcitonin during acute hypercalcemia
decreased the calcemic response to parathyroid hormone (PTH)
in azotemic rats [11]. This finding suggested that in renal failure,
calcitonin may play a role in the observed skeletal resistance to
PTH. While hypocalcemia is often observed in renal failure, it
is not known whether an increase in serum calcium within the
physiologic range stimulates calcitonin secretion. If this were
true, then the stimulation of calcitonin may decrease the
calcemic response to PTH in renal failure. A better understand-
ing of the serum calcium-calcitonin relationship should help to
clarify these questions.
The purpose of this study was to evaluate in renal failure, the
relationship between serum calcium and calcitonin, and
whether calcitonin is stimulated in the physiologic range of
serum calcium. To provide appropriate comparisons, normal
and parathyroidectomized rats were also studied.
Methods
Four groups of pair-fed, male Wistar rats weighing between
200 and 300 grams were evaluated. The groups were normals
(N, N = 9), parathyroidectomy (PTX, N = 18), and two groups
of rats with renal failure (RFa and RFb); the latter two groups
were divided according to the basal serum calcium concentra-
tion. The RFa group (N 8) had a basal serum calcium less than
8.5 mg/dl and the RFb group (N = 10) had a basal serum calcium
concentration greater than 8.5 mg/dl. In the PTX group, a
selective parathyroidectomy was performed with the aid of a
dissecting microscope and the adequacy of parathyroid removal
was confirmed by a decrease in the serum calcium concentra-
tion below 7 mg/dl during a calcium restricted diet (calcium
<0.05%, phosphate 0.8%) for five days. The rats in the PTX
group were then returned to a regular diet (calcium 1.2%,
phosphate 0.9%). In the two RF groups, renal failure was
surgically induced by ligation of two of three main arteries in
the hilum of the left kidney followed one week later by a right
nephrectomy. Sham operations for renal failure were performed
in rats in the N and PTX groups. For any surgical procedure or
blood drawing, rats were anesthetized with sodium pentobar-
bital, 50 mg/kg, administered intraperitoneally. To induce dif-
ferent levels of serum calcium in the two RF groups, rats were
either placed on a high phosphate diet (calcium 0.6%, phos-
phate 1.2%) to induce hypocalcemia or a regular diet to main-
tain normal levels of serum calcium. Normal rats were fed a
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Table 1. Serum levels of calcium, phosphorus, creatinine, and calcitonin before and after parathyroid hormone infusion
RFa RFb
Basal serum calcium
Serum level N PTX <8.5 mg/dl > 8.5 mg/dl
N
Calcium
mg/di
Before
After
9
9.70 0.27
14.15 0.59a
18
6.92 036b
11.32 0•59a.b
8
7•35 0.3l
10.35 052a.b
10
9•75 2c.d
11.55 033a.b
Phosphoruse
mg/dl
Before
After
10.27 0.73
6.62 0.35a
12.37 0.838.89 0.34' 13.38 1,11b7.66 1.52a 10.19
0•52d
9.67 067b
Creatinine
mg/di
Before
After
0.30 0.03
0.34 0.03
0.23 0.02
0.27 0.03
0.84 0.070.88 0.08 0.70 0b,c0.75 0.07
Calcitonin
pg/mi
Before
After
10.5 1.2
39.2 2.5
10.1 1.0
28.7 3.6a
12.4 1.IC
45.7 6.8ac
18.2 21b.c,d
31.0 4.I'
Data are mean SE.
a P < 0.01 as compared with before PTH infusion
b P < 0.01 as compared with N
P < 0.01 as compared with PTX
d P < 0.01 as compared with RFa
e Rats in the N and RFa groups received a high phosphate diet
high phosphate diet. Except for the calcium restricted diet in
the PTX group, all study diets were administered for the two
weeks after the right nephrectomy or the sham operation. All
rats were fed sixteen grams of food per day.
Two weeks after the induction of renal failure or the sham
operation, rat 1-34 PTH (Bachem, Torrance, California, USA)
was infused for 48 hours to increase the serum calcium concen-
tration. To vary the increment in serum calcium, the rate of
PTH infusion ranged from 0.8 to 2.5 U/100 grams-body wt/hr.
The PTH was infused via a subcutaneously implanted minios-
motic pump (model 2001, Aiza, Palo Alto, California, USA).
Before placement in the miniosmotic pump, the PTH was
diluted in 0.9% normal saline with 2% cysteine HC1 added to
decrease the pH of the solution to 1.5. During the PTH infusion,
all rats were maintained on a low calcium and low phosphate
diet (calcium <0.05%, phosphate <0.2%) to minimize gastro-
intestinal absorption of calcium and phosphate. On the morning
before any procedure or blood drawing, rats were fasted
overnight, and were fed after the blood drawing or the comple-
tion of the procedure.
Immediately before the PTH infusion, blood was obtained
from the tail vein and at sacrifice 48 hours later by cardiac
puncture. At both intervals, serum calcium, phosphorus, cre-
atinine, and calcitonin were measured. In addition, in the N and
the two RF groups, blood was also obtained from one or two
rats at 24 hours. In the PTX and RFa groups, serum for basal
and stimulated calcitonin was not available for measurement at
both intervals in all rats. Serum calcium was measured by
atomic absorption (Perkin-Elmer, Norwalk, Connecticut,
USA), serum phosphorus with a kit for phosphorus (Sigma
Chemical Co., St. Louis, Missouri, USA), and serum creatinine
with a specific analyzer for creatinine (Creatinine Analyzer 2,
Beckman Instruments, Fullerton, California, USA). Serum
levels of calcitonin were measured with a commercially avail-
able radioimmunoassay (Nichols, San Juan Capistrano, Califor-
nia, USA) that uses a goat antibody raised against synthetic
human calcitonin. The validity of this assay in rats has been
shown previously [12]. Intraassay and interassay coefficients of
variation for the calcitonin assay were 7.5% and 9.5%, respec-
tively. The lower limit of detection was 7 pg/ml.
Biochemical data were analyzed using analysis of variance
followed by the Duncan test for multiple comparisons between
groups; in addition a paired i-test was used to compare values
from the same group. A P value < 0.05 was considered
statistically significant. All values are expressed as the mean
standard error (SE).
Results
In Table 1, the serum levels of calcium, phosphorus, creati-
nine, and calcitonin are shown before and after the PTH
infusion. The basal serum calcium level was lower in the PTX
group, and by definition in the RFa group. As expected, the
serum creatinine level was higher in the two RF groups. In all
groups, the PTH infusion induced a significant increase in
serum calcium and calcitonin. Serum phosphorus decreased
after the PTH infusion and a reduction in dietary phosphate. As
compared with the N group, the other three groups had a lower
serum calcium concentration after the PTH infusion. The serum
phosphorus level was higher in the PTX and RFb groups, and
the serum creatinine level was unchanged after the PTH infu-
sion.
In Figure 1, the serum level of calcitonin in each group is
separated according to the serum calcium concentration: low
(<8.5 mgldl), normal (8.5 to 11 mg/dl), and high (> 11 mgldl).
Hypocalcemia was not observed in the N and RFb groups. In all
four groups, an increase in the serum calcium concentration
from one defined range of serum calcium to the next higher
level, produced a significant increase in serum calcitonin. In
hypocalcemia (< 8.5 mgldl), the serum calcitonin level was
greater in the RFa than the PTX group. In the normal range of
serum calcium and for a similar mean serum calcium level, the
serum calcitonin level was greater in the PTX, RFa, and RFb
groups than the N group. During hypercalcemia, no significant
differences in calcitonin levels were observed between groups.
Finally, the serum calcitonin concentration was greater in the
basal state in the RFb than the RFa group. The respective serum
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Fig. 1. The stimulation of serum calcitonin by increases in the serum
calcium is shown in the four groups, normals, parathyroidectomy
(PTX), and the Iwo renal failure groups, RF, and RFb. The serum
calcitonin level is shown for each range of serum calcium, (U) < 8.5
mgldl, () 8.5 to 11 mg/dl, and (D)> 11 mg/dl. In each group, the serum
calcitonin level was significantly greater than the calcitonin level at the
previous range of serum calcium. *D < 0.05 as compared with normals;
+P < 0.05 as compared with PTX; #P < 0.05 as compared with RFa.
calcium concentrations were 7.35 .31 (RFa) versus 9.75 .20
(RFb) mg/dl.
In Figure 2, the relationship between serum calcium and
calcitonin is displayed. In Figure 2A, a composite of the four
groups is shown and in Figures 2 B through D, the individual
groups. As can be observed overall and for each group, a
progressive increase in the serum calcium concentration pro-
duced an increase in serum calcitonin. Moreover, the relation-
ship appeared to be best represented as a sigmoidal curve. As
observed in Figure 2A, the calcitonin-calcium curve in the two
groups with hypocalcernia, PTX and RFa, appeared to be
shifted to the left of the other two groups. In renal failure (Fig.
2D), the calcitonin-calcium curve was different between the two
RF groups. In RFa with a lower basal serum calcium level, the
calcitonin-calcium curve was positioned to the left of the same
curve for the RFb group; thus, for the same serum calcium
concentration, the serum calcitonin concentration was greater
in the RFa than in the RFb group.
Discussion
To induce hypocalcemia, rats with normal renal function
were subjected to parathyroidectomy and rats with renal failure
were fed a high phosphate diet. As a result, serum calcitonin
levels could be obtained during hypocalcemia and then evalu-
ated as the serum calcium increased. Our results demonstrate
that serum calcitonin secretion was stimulated not only by
hypercalcemia, but by an increase in the serum calcium during
the transition from hypocalcemia to a normal serum calcium
level, even when the serum calcium concentration increased
within the normal range of serum calcium. However, in at least
the N, PTX, and RFb groups, the increase in serum calcitonin
did not parallel the increase in serum calcium inasmuch as the
serum calcitonin tended to attain maximal levels at a serum
calcium concentration of approximately 12 to 13 mgldl. Finally,
the relationship between serum calcium and calcitonin was best
represented as a sigmoidal curve.
Previous studies have indicated that some variation in serum
calcitonin levels may occur due to diurnal rhythms. These
variations may be induced by feeding [13] or anticipation of
feeding [14]. In addition, it has been reported that increases in
serum calcitonin induced by feeding are less in male rats [131. In
the present study, rats were fasted overnight and fed after blood
was drawn in the morning. Thus, since feeding was regular,
blood was drawn at a similar time during the day, and all rats
were male, it is likely that the serum calcitonin levels were not
significantly affected by diurnal variations.
A decreased calcemic response to a PTH infusion is a well
recognized finding in renal failure [15—17]. This phenomenon is
believed to be secondary to factors which result from renal
failure. These factors include decreased calcitriol levels [15],
hyperphosphatemia [16], and down regulation of bone receptors
for PTH [17]. In a recent study, we observed that during
hypercalcemia induced by a P1'H infusion, calcitonin stimula-
tion decreased the calcemic response to PTH [11]. However,
our previous study did not address if in renal failure, an increase
in serum calcium that did not induce hypercalcemia stimulated
calcitonin release. In the present study, we found that calcito-
nm release was stimulated in renal failure by an increase in the
serum calcium even though the serum calcium concentration
remained in the normal range. This finding suggests that calci-
tonin stimulation may modify the calcemic response to PTH in
renal failure even in the absence of hypercalcemia.
At similar serum calcium concentrations, differences in basal
calcitonin levels were observed between the PTX and RFa
groups during hypocalcemia and between the N and RFb groups
at a serum calcium concentration between 8.5 and 11 mg/dl. The
higher calcitonin level in azotemic rats was likely due to
decreased renal clearance of calcitonin [5—8]. Finally, renal
function did not appear to change during the infusion of PTH.
Thus, although it was not possible to measure intact calcitonin,
the increase in serum calcitonin, as measured by a carboxy-
terminal assay, most likely represented an increase in calcitonin
secretion rather than a difference in renal clearance.
For the first time to our knowledge, the calcitonin-calcium
relationship has been defined throughout a wide range of serum
calcium levels. This type of relationship is well described
between PTH and calcium, and is generally represented as a
sigmoidal curve [18, 19]. However, as opposed to the PTH-
calcium curve in which lowering of the serum calcium stimulates
PTH production, elevation of the serum calcium concentration
stimulated calcitonin. Our findings in parathyroidectomized,
normal, and azotemic rats would suggest that the relationship
between serum calcitonin and calcium is best represented as a
sigmoidal curve. Another important observation was that hy-
pocalcemia appeared to shift the calcitonin-calcium curve to the
left, but did not alter the magnitude of the calcitonin response to
hypercalcemia. Thus, for the same serum calcium concentra-
tion, the calcitonin level was greater in the normal range of
serum calcium when the initial serum calcium concentration
was low. This was especially striking in rats with renal failure,
and thus raises the possibility that calcitonin may be an impor-
tant factor modifying the calcemic response to PTH in renal
*
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failure even during hypocalcemia. Further studies, including
information in humans, may lead to a better understanding of
the physiologic significance of these findings.
The presence of a calcitonin-calcium curve suggests the
possibility of a regulatory function for calcitonin. In this study,
the serum calcitonin concentration at the ambient serum cal-
cium level was positioned at the base of the slope of the
calcitonimcalcium curve. Thus, any increase in the serum
calcium elicited a sharp rise in serum calcitonin. This is
analogous to the PTH-calcium curve in which the basal PTH
level is positioned at the base of the slope and a minimal
decrease in the serum calcium concentration produces a
marked increase in PTH [18, 201. However, while hypocalcemia
increases PTH messenger RNA synthesis [21, 22], hypercalce-
mia has not been reported to increase the synthesis of calcitonin
messenger RNA [21]. Thus, the increase in calcitonin induced
by hypercalcemia may be entirely due to the release of stored
hormone. In the three groups in which PTH-induced hypercal-
cemia exceeded 12 mgldl, the serum calcitonin level appeared
to peak at a serum calcium between 12 and 13 mgldl, and then
either plateau or decline. Thus, if it is true that hypercalcemia
does not increase calcitonin synthesis, this observation would
suggest that calcitonin stores were depleted. A more remote
possibility is that marked hypercalcemia alters the release of
calcitonin.
In summary, calcitonin was stimulated as the serum concen-
tration increased from hyppcalcemia to normal serum calcium
levels. This was observed both in the absence and presence of
renal failure. The correlation between serum calcitonin and
calcium was best expressed as a sigmoidal curve. In conclusion:
1) the presence of a calcitonin-calcium curve suggests the
possibility of a regulatory function for calcitonin during acute
increases in the serum calcium concentration; 2) the basal
serum calcium level may determine the level of calcium at
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which calcitonin is stimulated; and 3) the stimulation of calci-
tonin in the physiologic range of serum calcium suggests that
endogenous calcitonin production may decrease the calcemic
response to PTH in renal failure.
Reprint requests to Mariano Rodriguez, M.D., Division of Nephrol-
ogy (WI] IL), Wadsworth VA Medical Center, Wilshire and Sawtelle
Blvds., Los Angeles, California 90073, USA.
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